LDCT Screening Results among Health Check-ups Population

Author:

Bao Ting1,Liu Bingqing2,Li Ruicen1,Li Zhenzhen1,Ji Guiyi1,Wang Youjuan1,Yang Hanwei1,Li Weimin3,Huang Wenxia4,Huang Yan4,Tang Huairong4

Affiliation:

1. Health Management Center, General Practice Medical Center, West China Hospital, Sichuan University

2. Sichuan University

3. Sichuan University West China Hospital

4. General Practice Medical Center, Sichuan University

Abstract

Abstract Objective To compare the LDCT screening results between eligible and ineligible screening candidates in preventive health check-ups population. Study Design and Setting Using a real-world LDCT screening results among people who took yearly health check-up in health management center of West China Hospital between 2006 and 2017. Objects were classified according to the China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2018 version) eligibility criteria. Descriptive analysis were performed between eligible and ineligible screening candidates. Results The proportion of ineligible screening candidates was 64.13% (10259), and among them there were 4005(39.04%) subjects with positive screenings, 80 cases had a surgical lung biopsy. Pathology results from lung biopsy revealed 69 cancers (true-positive) and 11 benign results (false-positive). The difference of the false-positive biopsy rate between ineligible screening candidates (13.75%) and eligible screening candidates(15.00%) was no statistically significant (P>0.05). Further, in ineligible screening candidates, the proportion of current smokers was higher among males compared to females (53.85% vs. 4.88%, P<0.05). Of the 69 lung cancer patients detected in ineligible screening candidates, lung adenocarcinoma accounts for a high proportion of lung cancers both in male (75.00%) and female (85.00%). Conclusion The proportion of ineligible screening candidates was high in health check-ups population.

Publisher

Research Square Platform LLC

Reference31 articles.

1. Cancer statistics in China, 2015;Chen W;CA: a cancer journal for clinicians,2016

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA: a cancer journal for clinicians,2018

3. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle DR;The New England journal of medicine,2011

4. Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology;Wood DE;Journal of the National Comprehensive Cancer Network: JNCCN,2018

5. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report;Mazzone PJ;Chest,2018

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3